N-(6-FLUORO-1H-INDAZOL-5-YL)-6-METHYL-2-OXO-4-[4-(TRIFLUOROMETHYL)PHENYL]-3,4-DIHYDRO-1H-PYRIDINE-5-CARBOXAMIDE, 95%, 5mg

N-TOSYL-D-PHENYLALANINE, 95.0%, 5g

2-(2-(N-(4-(Isopropyl)phenyl)carbamoyl)phenyl)acetic acid, 98%, 10g

Melting crucible 79 low form, 20 ml, 0, 10 Piece(s)

(R)-(-)-1-Amino-2-propanol>97.0%(GC)(T)25g

(R)-1-phenylethanamine (2R,3R,4S)-4-(benzo[d][1,3]dioxol-5-yl)-1-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylate, 98%, 25mg

5-(2-furyl)-1,3,4-oxadiazole-2-thiol, 95.0%, 5g

D-Valine, 97.00%, 10g

((2R,7aR)-2-Fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol, 97%, 500mg

4-ethyl-5-methyl-1H-pyrazole, 95%, 5g

3,6-Dihydroxy-xanthen-9-one, 95.0%, 1g

2-chloro-5-cyclopropylpyrimidine, 95.0%, 1g

D-Galactoseamine hydrochloride, 98.0%, 500g